Building a database for motor neuron disease research
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study collects information from people with ALS or other motor neuron diseases to better understand how these conditions vary. By joining a database, you help researchers find patterns that could improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of ALS or another motor neuron disease.
- You are willing to have your medical information included in a research database.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers in people with ALS or other motor neuron diseases to better understand the different types of the disease. It may help find new ways to treat or manage these conditions.
This study looks at people with amyotrophic lateral sclerosis (ALS), people who might have ALS, and also people related to someone with ALS. It may help researchers better understand ALS and related “motor neuron” conditions, and it involves participation that may include blood tests.
This study collects information from people diagnosed with ALS and, if applicable, studies ALS tissue samples. It aims to improve understanding of ALS using patient records and donated materials, which may help future treatments.
This study is a research collaborative that collects information from people with ALS or their families. It aims to better understand the disease and find markers that could help develop treatments.
This study is a national registry that collects information from people with amyotrophic lateral sclerosis (ALS) to better understand the disease. Joining may help researchers learn about patterns of symptoms and care over time.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.